Prostate tumors downregulate microseminoprotein‐beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|78|4|257-265

ISSN： 0270-4137

Source： THE PROSTATE, Vol.78, Iss.4, 2018-03, pp. : 257-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nonepithelial Tumors and Tumor-Like Lesions of the Prostate Gland

By Shabaik A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 40, Iss. 4, 2003-07 ,pp. : 429-472

Informa Healthcare

Access to resources Recommend Favorite

MANAGEMENT OF BENIGN HYPERTROPHY OF THE PROSTATE

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 2, Iss. 6, 1954-06 ,pp. : 400-404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of fractures associated with treatment for benign prostate hyperplasia in men

By Vestergaard P.   Rejnmark L.   Mosekilde L.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 731-737

Springer Publishing Company

Access to resources Recommend Favorite

On complexity and homogeneity measures in predicting biological aggressiveness of prostate cancer; Implication of the cellular automata model of tumor growth

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 8, 2015-12 ,pp. : 791-801

John Wiley & Sons Inc

Access to resources Recommend Favorite

Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early‐stage prostate cancer

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3446-3453

John Wiley & Sons Inc

Access to resources Recommend Favorite